Chemopreventive potential of epigallocatechin gallate and genistein: Evidence from epidemiological and laboratory studies

Toxicology Letters

Volumn 150, Issue 1, 2004, Pages 43-56

  Park, Ock Jin ^a   Surh, Young Joon ^b  

^a Hannam University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Chemoprevention; Epigallocatechin gallate (EGCG); Genistein; Green Tea; Intracellular signaling cascades; Soy isoflavone

Indexed keywords

CASPASE 3; CYCLIN B1; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIGALLOCATECHIN GALLATE; GELATINASE B; GENISTEIN; PROTEIN P53; PROTEIN TYROSINE PHOSPHATASE; TRANSFORMING GROWTH FACTOR ALPHA;

ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ASIAN; BREAST CARCINOMA; CANCER RISK; CARCINOGENESIS; CELL COMMUNICATION; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL GROWTH; CHEMOPROPHYLAXIS; DIETARY INTAKE; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; ENZYME INDUCTION; ENZYME INHIBITION; FOOD ANALYSIS; FOOD INTAKE; HUMAN; IN VITRO STUDY; INTRACELLULAR SPACE; LABORATORY TEST; NONHUMAN; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROSTATE CARCINOMA; REGULATORY MECHANISM; REVIEW; RISK ASSESSMENT; SKIN CARCINOGENESIS; SOYBEAN; TEA; TUMOR SUPPRESSOR GENE;

ANIMALIA;

EID: 1842584266     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2003.06.001     Document Type: Article

References (125)

1. Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., Okada H. Urinary excretion of lignins and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional diet. Am. J. Clin. Nutr. 54:1991;1093-1100.
2. Ahmad N., Adhami V.M., Gupta S., Cheng P., Mukhtar H. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Arch. Biochem. Biophys. 398:2002;125-131.
3. Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistien, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262:1987;5592-5595.
4. Alhasan S.A., Ensley J.F., Sarkar F.H. Genistein induced molecular changes in a squamous cell carcinoma of the head and neck cell line. Int. J. Oncol. 16:2000;333-338.
5. Allred C.D., Allred K.F., Virant S.M., Helferich W.G. Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner. Cancer Res. 61:2001;5045-5050.
6. Annabe B., Bousquet-Gagnon N., Page M., Gingras D., Belivear R. Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells. Biochim. Biophys. Acta. 1542:2002;209-220.
7. Arts I.C., Jacobs D.R., Gross M., Harnack L.J., Folsom A.R. Dietary catechins and cancer incidence among postmenopausal women: the Iowa Women's Health Study (United States). Cancer Causes Control. 13:2002;373-382.
8. 2 levels in rectal mucosa in humans. Cancer Epidemiol. Biomarkers Prev. 8:1999;709-713.
9. Barthelman M., Bair W.B., Stickland K.K.et al. (-)-Epigallocatechin-3- gallate inhibition of ultrviolet B-induced AP-1 activity. Carcinogenesis. 19:1998;2201-2204.
10. Bhatia N., Zi X., Agarwal R. Enhanced polyphenolic nature of flavonoid antioxidants plays a detrimental role in the activation of survival factor Akt and apoptosis in prostate cancer DU145 cells: A comparison of silymarin, genistein and EGCG. Proc. Am. Assoc. Cancer Res. 40:1999;533.
11. Bhatia N., Agarwal C., Agarwal R. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells. Nutr. Cancer. 39:2001;292-299.
12. Blanco A., Habib A., Levy-Toledano S., Maclouf J. Involvement of tyrosine kinases in the induction of cyclo-oxygenase in human endothelial cells. Biochem. J. 312:1995;419-423.
13. Bode A.M., Dong Z. Signal transduction pathways: target for green and black tea polyphenols. J. Biochem. Mol. Biol. 36:2002;66-77.
14. Brzozowski A.M., Pike C.W., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
15. Cao Y., Cao R., Brakenhielm E. Antianiogenic mechanisms of diet-derived polyphenols. J. Nutr. Biochem. 13:2002;380-390.
16. CIP1 is dispensable for the G2 arrest caused by genistein in human melanoma cells. Exp. Cell Res. 258:2000;101-108.
17. Casagrande F., Darbon J.-M. Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cylcin-dependent kinases CDK2 and CDK1. Biochem. Pharmacol. 61:2001;1205-1215.
18. Chen W., Bowden G.T. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene. 18:1999a;7469-7476.
19. Chen W., Garthelman M., Lin L., Bowden G.T. EGCG inhibits UVB-induced AP-1 activation and c-fos gene expression in a human keratinocyte cell line. Proc. Am. Assoc. Cancer Res. 39:1998;391.
20. Chen W., Dong Z., Valcic S., Timmermann B.N., Bowden G.T. Inhibition of ultraviolet B-induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line. Mol. Carcinog. 24:1999b;79-84.
21. Chen C., Yu R., Owuor E.D., Kong A.N. Activation of antioxiant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23:2000;605-612.
22. 2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91:1998a;164-173.
23. 2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells. Int. J. Oncol. 13:1998b;391-396.
24. 2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Jpn. J. Cancer Res. 91:2000;164-173.
25. Chung J.Y., Park J.O., Phyu H., Dong Z., Yang C.S. Mechanisms of inhibition of the Ras-MAP kinase signaling pathway in 30.7b Ras 12 cells by tea polyphenols(-)-epigallocatechin-3-gallate and theaflavin-3,3′-digallate. FASEB J. 15:2001;2022-2024.
26. 2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells. Eur. J. Cancer. 34:1998;1927-1934.
27. Darbon J.-M., Penary J., Escalas N., Casagrande F., Goubin-gramatica F., Baudouin C., Ducommun B. Distinct Chk2 activation pathways are triggered by genistein and DNA-damaging agents in human melanoma cells. J. Biol. Chem. 275:2000;15363-15369.
28. 1 and induction of apoptosis in prostate cancer cells. Nutr. Cancer. 32:1998;123-131.
29. Davis J.N., Kucku O., Sarkar F.H. Genistein inhibits NF κB activation in prostate cancer cell. Nutr. Cancer. 35:1999;167-174.
30. Dean N.M., Kanemitsu M., Boynton A.L. Effects of the tyrosine-kinase inhibitor genistein on DNA synthesis and phopholipid-derived second messenger generation in mouse 10T1/2 fibroblasts and rat liver T1B cells. Biochem. Biophys. Res. Comm. 165:1989;795-801.
31. Dong Z. Effects of food factors on signal transduction pathways. Biofactors. 12:2000;17-28.
32. Fotsis T., Pepper M., Adlercreutz H., Hase T., Montesano R., Schweigerer L. Genestein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis. J. Nutr. 125:1995;790S-797S.
33. Fotsis T., Pepper M.S., Aktas E., Breit S., Rasku S., Adlerctrutz H., Wahala R., Montesano R., Schweigerer L. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Res. 57:1997;2916-2921.
34. Fujiki H., Suganuma M., Okabe S., Sueoka E., Sueoka N., Fujimoto N., Goto Y., Matsuyama S., Imai K., Nakachi K. Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1. Mutat. Res. 480-481:2001;299-304.
35. Fujita Y., Yamane T., Tanaka M., Kuwata K., Okazumi J., Takahashi T., Fujike H., Okuda T. Inhibitory effect of (-)-epigallocatechin gallate on carcinogenesis with N-ethyl-N′-nitro-N-nitrosoguanidine in mouse duodenum. Jpn. J. Cancer Res. 80:1989;503-505.
36. Garbisa S., Sartor L., Biggin S., Salvato B., Benelli R., Albini A. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer. 91:2001;822-832.
37. Goodman M.T., Wilkens L.R., Hankin J.H., Hyu L.-C., Wu A.H., Kolonel L.N. Association of soy and fiber consumption with the risk of endometrial cancer. Am. J. Epidemiol. 146:1997;294-306.
38. Herbert J., Hurley T., Olendzki B., Teas J., Yunsheng M.et al. Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study. J. Nat. Cancer Inst. 90:1998;1637-1647.
39. Herschman H.R. Prostaglandin synthase 2. Bioch. Biophys. Acta. 1299:1996;125-140.
40. Hirose M., Mizuguchi Y., Yaono M., Tanaka H., Yamaguchi T., Shirai T. Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pre-treated with 7,12-dimethyl-benz(a)anthracene. Cancer Lett. 112:1997;141-147.
41. Hong J., Smith T.J., Ho C.-T., August D.A., Yang C.S. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem. Pharmacol. 62:2001;1175-1183.
42. Howe L.R., Dannenberg A.J. A role of cycooxygenase-2 inhibitors in the prevention and treatment of cancer. Semin. Oncol. 29:2002;111-119.
43. Hsieh C.Y., Santell R.C., Haslam S.Z., Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58:1998;3833-3838.
44. Hsu S., Lewis J.B., Borke J.L., Singh B., Dickinson D.P., Caughman G.B., Athar M., Drake L., Aiken A.C., Huynh C.T., Das B.R., Osaki T., Schuster G.S. Chemopreventive effects of green tea polypheniols correlate with reversible induction of p57 expression. Anticancer Res. 21:2001;3743-3848.
45. Hsu S., Singh B.B., Lewis J.B., Borke J.L., Dickinson D.P., Drake L., Caughman G.B., Schuster G.S. Chemoprevention of oral cancer by green tea. Gen. Dent. 50:2002;140-146.
46. Imai K., Suga K., Nakachi K. Cancer-preventive effects of drinking green tea among a Japanese population. Prev. Med. 26:1997;769-775.
47. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-oestrogens and breast cancer. Lancet. 350:1997;990-994.
48. Inoue M., Tajima K., Hirose K., Hamajima N., Takezake T., Kuroishi T., Tominaga S. Tea and coffee consumption and risk of digestive tract cancers: data from a comparative case-referent study in Japan. Cancer Causes Control. 9:1998;209-216.
49. Ji B.T., Chow W.H., Hsing A.W., McLaughlin J.K., Dai Q., Gao Y.T., Blot W.J., Fraumeni J.F. Jr. Green tea consumption and the risk of pancreatic and colorectal cancers. Int. J. Cancer. 70:1999;255-258.
50. Jung Y.D., Ellis L.M. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int. J. Exp. Pathol. 82:2001;309-316.
51. Jung Y.D., Kim M.S., Shin B.A., Chay K.O., Ahn B.W., Liu W., bucana C.E., Gallick G.E., Ellis L.M. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br. J. Cancer. 84:2001;844-850.
52. Katiyar S.K., Agarwal R., Wood G.S., Mukhtar H. Inhibition of phorbol ester tumor promoter 12-O-tetradecanoylphorbol-13-acetated-caused tumor promotion in 7,12-dimethylbenz[a]anthracene-iniated SENCAR mouse skin by a polyphenolic fraction isolated from green tea. Cancer Res. 52:1992;6890-6897.
53. Katiyar S.K., Agarwal R., Zaim M.T., Mukhtar H. Protection against N-nitrosodiethylamine and benzo[a]pyrene-induced forestomach and lung tumorigenesis in A/J mice by green tea. Carcinogenesis. 14:1993;849-855.
54. Katiyar S.K., Afaq F., Azzizuddin K., Mukhtar H. Inhibition of UVB-induced oxidative stress-mediated phosphorylation of mitogen-activated protein kinase signaling pathways in cultured human epidermal keratonocytes by green tea polyphenol(-)-epigallocatechin-3-gallate. Toxicol. Appl. Pharmacol. 176:2001;110-117.
55. Kresty L.A., Morse M.A., Morgan C., Carlton P.S., Lu J., Gupta A., Blackwood M., Stoner G.D. Chemoprevention of esophageal tumorigenesis by dietary adminstration of lyophilized black raspberries. Cancer Res. 61:2001;6112-6119.
56. Kruse F.E., Joussen A.M., Fotsis T., Schweigerer L., Rohrschneider K., Vlocker H.E. Inhibition of neovascularization of the eye by dietary factors exemplified by isoflavonoids. Ophthalmologe. 94:1997;152-156.
57. Kong A.N., Chen C., Mandlekar S., Primiano T. Signal tranduction events elicited by natural products: role of MAPK and caspase pathways in homeostatic response and induction of apoptosis. Arch. Pharm. Res. 23:2000;1-16.
58. Kumi-Kiaka J., Sanderson N.A., Hall A. The mediating role of caspase-3 protease in the intracellular mechanism of genistein-induced apoptosis in human prostatic carcinoma cell lines, DU 145 and LNCaP. Biol. Cell. 92:2000;595-604.
59. Kuroda Y., Hara Y. Antimutagenic and anticarcinogenic activity of tea polyphenols. Mutat. Res. 436:1999;69-97.
60. CIP1/WAF1 expression and blocks the G1 to S phase transition in mouse fibroblast and melanoma cells. Biochem. Biophys. Res. Commun. 251:1998;291-295.
61. Lamatiniere C.A., Cotroneo M.S., Fritz W.A., Wang J., Mentor-Marcel R., Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J. Nutr. 132:2002;552S-558S.
62. Lamy S., Gingras D., Beliveau R. Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation. Cancer Res. 62:2002;381-385.
63. Lee H.P., Gourley L., Duffy S.W., Esteve J., Lee J., Day N.E. Dietary effects on breast cancer risk in Singapore. Lancet. 336:1991;1197-1200.
64. Leung L.K., Wang T.T. Bcl-2 is not reduced in the death of MCF-7 cells at low genistein concentration. J. Nutr. 130:2000;2922-2926.
65. Li Y., Upadhyay S., Bhuiyan M., Sarkar F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 18:1999;3166-3172.
66. WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. Nutr. Cancer. 31:1998;184-191.
67. Lian F., Li Y., Bhuiyan M., Sarkar F.H. p53-independent apoptosis induced by genistein in lung cancer cells. Nutr. Cancer. 33:1999;125-131.
68. Liang Y., Huang Y., Tsai S., Lin-Shiau S., Chen C., Lin J. Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis. 20:1999a;1945-1952.
69. Liang Y.C., Lin-Shiau S.Y., Chen C.F., Lin J.K. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell. Biochem. 75:1999b;1-12.
70. 2/M arrest and inhibits apoptosis. Carcinogenesis. 21:2000;1941-1945.
71. Liu J.D., Chen S.H., Lin C.L., Tsai S.H., Liang Y.C. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3- gallate and dacarbazine in mice. J. Cell. Biochem. 83:2001;631-642.
72. Lopez-Ilasaca M. Signaling from G-protein-coupled receptors to mitogen-activated protein (MAP) kinase cascades. Biochem. Pharmacol. 56:1998;269-277.
73. Lu Y.P., Lou Y.R., Lin Y., Shih W.J., Huang M.T., Yang C.S., Conney A.H. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res. 61:2001;5002-5009.
74. Maggiolini M., Bonofiglio D., Marsico S., Panno M.L., Cenni B., Picard D., Ando S. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol. Pharmacol. 60:2001;595-602.
75. Majima T., Tsutsumi M., Nishino H., Knishi Y. Inhibitory effects of beta-carotene, palm carotene, and green tea poly-phenols on pancreatic carcinogenesis initiated by N-nitrosobis(20oxopropyl)amine in Syrian golden hamsters. Pancreas. 16:1998;13-18.
76. Markovits J., Linassier C., Fosse P., Couprie J., Pierre J., Jacquemin-Sablon A., Saucier J.-M., Larsen A.K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49:1989;5111-5117.
77. Martin P.M., Horwitz K.B., Ryan D.S., McGuire W.L. Phytoestrogen interaction with estrogen receptros in human breast cancer cells. Endocrinology. 103:1978;1860-1867.
78. Masuda M., Suzui M., Weinstein I.B. Effects of epigallocatechin-3- gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines. Clin. Cancer Res. 12:2001;4220-4229.
79. 2/M. Cancer Res. 53:1993;1328-1331.
80. Metz N., Lobstein A., Schneider Y., Gosse F., Schleiffer R., Anton R., Raul F. Suppression of Azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr. Cancer. 38:2000;60-64.
81. Mukhtar H., Ahmad N. Mechanism of cancer chemopreventive activity of green tea. Proc. Soc. Exp. Med. Biol. 220:1999;234-238.
82. Mutoh M., Takahashi M., Fukuda K., Matsushima-Hibiya Y., Mutoh H., Sugimura T., Wakabayashi K. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. Carcinogenesis. 21:2000;959-963.
83. Nakachi K., Suemasu K., Suga K., Takeo T., Imai K., Higashi Y. Influence of drinking green tea on breast cancer malignancy among Japanese patients. Jpn. J. Cancer Res. 89:1998;254-261.
84. Narisawa T., Fukura Y. A very low dose of green tea polyphenols in drinking water prevents N-methyl-N-nitrosourea-induced colon carcinogenesis in F344 rats. Jpn. J. Cancer Res. 84:1993;1007-1009.
85. Nomura M., Ma W., Chen N., Bode A.M., Dong Z. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappa B activation of tea polyphenols, (-)-epigallocatechin gallate and teaflavins. Carcinogenesis. 10:2000;1885-1890.
86. Nomura M., Kaji A., He Z., Ma W.Y., Miyamoto K., Yang C.S., Dong Z. Inhibitory mechanisms of tea polyphenols on the ultraviolet B-activated phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 276:2001;46624-46631.
87. Okura A., Arakawa H., Oka H., Yoshinari T., Monden Y. Effect of genistein on topoisomerase activity and on the growth of [VAL12] Ha-ras-transformed NIH3T3 cells. Biochem. Biophys. Res. Commun. 157:1988;183-189.
88. Pagliacci M.C., Smacchia M., Migliorati G., Grignani F., Riccardi C., Nicoletti I. Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer. 11:1994;1675-1682.
89. WAF1/CIP1 in human hepatocelluar and colorectal carcinoma cells. Int. J. Oncol. 18:2001a;997-1002.
90. Park J.W., Choi Y.J., Suh S.I., Kwon T.K. Involvement of ERK and protein tyrosine phosphatase signaling pathways in EGCG-induced cyclooxygenase-2 expression in Raw 264.7 cell. Biochem. Biophys. Res. Commun. 286:2001b;721-725.
91. Peterson G., Barnes S. Genistein inhibition of the growth of human breast cancer cells: independence from estrogen receptors and the multi-drug resistance gene. Biochem. Biophys. Res. Commun. 19:1991;661-667.
92. Peterson G., Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 7:1996;1345-1351.
93. Pianetti S., Guo S., Kavanagh K.T., Sonenshein G.E. Green tea polyphenol epigallocatechin-3 gallate inhibits Her-2/neu signaling, proliferation, and transformed phenotype of breast cancer cells. Cancer Res. 62:2002;652-655.
94. Pisters K.M., Newman R.A., Coldman B., Shin D.M., Khuri F.R., Hong W.K., Glisson B.S., Lee J.S. Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 19:2001;1830-1838.
95. Sartor L., Pezzato E., Dell'Aica I., Caniato R., Biggin S., Garbisa S. Inhibition of matrix-proteases by polyphenols: chemical insights for anti-inflammatory and anti-invasion drug design. Biochem. Pharmacol. 64:2002;229-237.
96. 2/M arrest, and apoptosis. J. Cell. Biochem. 69:1998a;44-54.
97. Shao Z.M., Wu J., Shen Z.Z., Barsky S.H. Genistein exerts multiple suppressive effects on human breast carcinoma cell. Cancer Res. 58:1998b;4851-4857.
98. Shao Z.M., Shen Z.Z., Fontana J.A., Barsky S.H. Genistine's "ER-dependnet and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res. 20:2000;2409-2416.
99. 1 cell-cycle arrest in human prostate cancer cells. Mol. Carcinog. 29:2000;92-102.
100. Sherr C.J., Roberts J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev. 9:1995;1149-1163.
101. Shutt D.A., Cox R.I. Steroid and phytoestrogen binding to sheep uterine receptors in vitro. J. Endocrinol. 52:1972;299-310.
102. Suganuma M., Okabe S., Sueoka N., Sueoka E., Matsuyama S., Imai K., Nakachi K., Fujiki H. Green tea and cancer chemoprevention. Mutat. Res. 428:1999;339-344.
103. Surh Y.-J. Molecular mechanisms of chemopreventitive effects of selected dietary and medicinal phenolic substances. Mutat. Res. 428:1999;305-307.
104. Surh Y.-J. Cancer chemoprevention with dietary phytochemicals. Nature Rev. Cancer. 3:2003;768-780.
105. Swiercz R., Skrzypczak-Jankun E., Merrell M.M., Selman S.H., Jankun J. Angiostatic activity of synthetic inhibitors of urokinase type plasminogen activator. Oncol. Rep. 6:1999;523-526.
106. Tamura T., Nakae D., Horiguch K., Akai H., Kobayashi Y., Sato H., Tsujiuchi T., Denda A., Knishi Y. Inhibition by green tea extract of diethylnitrosamine-initiated but not choline-deficient, L-amino acid-defined diet-associated development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in rat liver. Jpn. J. Cancer Res. 88:1997;356-362.
107. Tanaka H., Hirose M., Kawabe M., Sano M., Takesada Y., Hagiwara A., Shirai T. Post-initiation inhibitory effects of green tea catechins on 7,12-dimethylbenz(a)anthracene-induced mammary gland carcinogenesis in female Sprague-Dawley rats. Cancer Lett. 116:1997;47-52.
108. Theard D., Coisy M., Ducommun B., Concannon P., Darbon J.M. Etoposide and adriamycin but not genistein can activate the checkpoint kinase Chk2 independently of ATM/ATR. Biochem. Biophys. Res. Commun. 289:2001;1199-1204.
109. Traganos F., Ardelt B., Halko N., Bruno S., Darzynkiewicz Z. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells. Cancer Res. 52:1992;6200-6208.
110. Twaddle G.M., Turbov J., Liu N., Murthy S. Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro. J. Surg. Oncol. 70:1999;83-90.
111. WAF1. Clin. Cancer Res. 7:2001;1782-1789.
112. Wang Z.-Y., Hoong J.-M., Huang M.-T., Reuhl K.R., Conney A.H., Yang C.S. Inhibition of N-nitrosodiethylamine-and 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced tumorigenesis in A/J mice by green tea and black tea. Cancer Res. 52:1992;1943-1947.
113. Wang Y., Yaping E., Zhang X., Lebwohl M., DeLeo V., Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis. 19:1998;649-654.
114. Wietrzyk J., Boratynski J., Grynkiewicz G., Ryczynski A., Radzikowski C., Opolski A. Antianiogenic and antitumour effects in vivo of genistein applied alone or combined with cyclophosphamide. Anticancer Res. 21:2001;3893-3896.
115. Xu J., Loo G. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J. Cell. Biochem. 82:2001;78-88.
116. Yamane T., Takahashi T., Kuwata K., Oya K., Inagake M., Kitao Y., Suganuma M., Fujiki H. Inhibition of N-mehtyl-N′-nitro-N-nitrosoguanidine- induced carcinogenesis by (-)-epigallocatechin gallate in the rat glandular stomach. Cancer Res. 55:1995;2081-2084.
117. Yang C.S. Inhibition of carcinogenesis by tea. Nature. 389:1997;134-135.
118. Yang C.S., Chung J.Y., Yang G.Y., Li C., Meng X., Lee M.J. Mechanisms of inhibition of carcinogenesis by tea. Biofactors. 13:2000;73-79.
119. Yang F., Oz H.S., Barve S., de Villiers W.J., McClain C.J., Varilek G.W. The green tea polyphenol (-)-epigallocatechin-3-gallate blocks nuclear factor-kappa B activation by inhibiting I kappa B kinase activity in the intestinal epithelial cell line IEC-6. Mol. Pharmacol. 60:2001;528-533.
120. Ye R., Bodero A., Zhou B., Khann K.K., Lavin M.F., Lees-Miller S.P. The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. J. Biol. Chem. 276:2001;4828-4833.
121. Zava D.T., Duwe G. Esrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer. 27:1997;31-40.
122. Zhang B., Li X., Nakama H., Zhang X., Wei N., Zhang X., Xhang L. A case-control study on risk of changing food consumption for colorectal cancer. Cancer Invest. 20:2002;458-463.
123. Zheng W., Dai Q., Custer L., Shu X.O., Wen W.Q., Jin F., Franke A.A. Urinary excretion of isoflavonoids and the risk of breast cancer. Cancer Epidemiol. Biomark. Prev. 8:1999;35-40.
124. Ziegler R.G., Hoover R.N., Pike M.C., Hildesheim A., Nomura A.M., West D.W., Wu-Williams A.H., Kolonel L.N., Horn-Ross P.L., Rosentha J.F.et al. Migration patterns and breast cancer risk in Asian-American women. J. Nat. Cancer Inst. 85:1993;1819-1827.
125. Zwiller J., Sassone-Corsi P., Kakazu K., Boyton A.L. Inhibition of PDGF-induced c-jun and c-fos expression by a tyrosine protein kinase inhibitor. Oncogene. 6:1991;219-221.